Tocotrienol as a Nutritional Supplement in Patients With Advanced Lung Cancer

NCT02644252 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

79

Enrollment

OTHER

Sponsor class

Stopped The trial was ended prematurely because of a poor accrual rate

Conditions

Lung Cancer

Interventions

DRUG: Day 1: Cisplatin 75 mg/m2
DRUG: Day 1: Vinorelbine 25 mg/m2
DRUG: Day 8: Capsule vinorelbine 50 mg/m2
DRUG: Day 1: Carboplatin AUC=5
DRUG: Day 1: Vinorelbine 30 mg/m2
DRUG: Day 8: Capsule vinorelbine 60 mg/m2
DIETARY_SUPPLEMENT: Tocotrienol 300 mg x 3 daily until progression
DRUG: Placebo 1 capsule x 3 daily until progression

Sponsor

Vejle Hospital